ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,360Medicare Part D Prescriptions Filled, Including Refills

Rank: 38 out of 1185

$856K Total Retail Price of All Prescriptions

Rank: 72 out of 1185

683 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 683 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

13% of this provider’s 683 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 15,339 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
LISINOPRIL 634 530 1 4
SIMVASTATIN 616 512 2 5
AMLODIPINE BESYLATE 614 533 3 1
FUROSEMIDE 582 513 4 8
LEVOTHYROXINE SODIUM 544 472 5 3
OMEPRAZOLE 522 430 6 6
WARFARIN SODIUM 517 492 7 21
HYDROCODONE-ACETAMINOPHEN 368 222 S3 8 2
LISINOPRIL-HYDROCHLOROTHIAZIDE 360 255 9 14
HYDROCHLOROTHIAZIDE 339 291 10 12
CITALOPRAM HBR 338 281 11 22
ATENOLOL 287 244 12 28
METOPROLOL SUCCINATE 285 250 13 20
ZOLPIDEM TARTRATE 283 214 14 15
POTASSIUM CHLORIDE 283 252 14 18
METFORMIN HCL ER 279 182 16 35
METOPROLOL TARTRATE 277 265 17 10
METFORMIN HCL 265 211 18 9
PRAVASTATIN SODIUM 255 232 19 7
MELOXICAM 236 192 20 27
GLIMEPIRIDE 211 146 21 49
GABAPENTIN 188 143 22 13
FLUTICASONE PROPIONATE 173 144 23 29
TRAMADOL HCL 171 133 24 16
ISOSORBIDE MONONITRATE ER 170 161 25 48
TRAZODONE HCL 165 140 26 38
CYMBALTA 163 142 27 44
SERTRALINE HCL 153 125 28 25
CLOPIDOGREL 151 144 29 31
MIRTAZAPINE 150 150 30 57
DONEPEZIL HCL 145 133 31 32
FAMOTIDINE 142 118 32 69
PREDNISONE 140 125 33 33
RANITIDINE HCL 135 109 34 17
TAMSULOSIN HCL 135 121 34 34
BENAZEPRIL HCL 135 123 34 41
DIGOXIN 133 120 37 67
AMLODIPINE BESYLATE-BENAZEPRIL 127 114 38 42
PLAVIX 119 109 39 45
ATORVASTATIN CALCIUM 118 102 40 11
CIPROFLOXACIN HCL 116 104 41 62
FLUOXETINE HCL 116 80 41 52
NEXIUM 113 71 43 19
CLONIDINE HCL 111 99 44 47
TRAMADOL HCL-ACETAMINOPHEN 110 88 45 128
LOSARTAN POTASSIUM 109 109 46 26
CRESTOR 101 54 47 23
LOSARTAN-HYDROCHLOROTHIAZIDE 92 83 48 36
VERAPAMIL ER 88 80 49 98
NAMENDA 84 74 50 43
LANTUS SOLOSTAR 83 78 51 104
LEVOFLOXACIN 81 69 52 109
KLOR-CON 10 81 75 52 118
CARVEDILOL 80 78 54 24
ESCITALOPRAM OXALATE 79 74 55 79
AZITHROMYCIN 77 65 56 39
KLOR-CON M20 76 75 57 59
PHENYTOIN SODIUM EXTENDED 76 58 57 111
ADVAIR DISKUS 76 60 57 54
ALLOPURINOL 74 71 60 30
ALENDRONATE SODIUM 73 73 61 40
DILTIAZEM 24HR CD 72 51 62 123
CYCLOBENZAPRINE HCL 70 55 R 63 53
VENLAFAXINE HCL ER 66 41 64 105
CEPHALEXIN 65 50 65 103
SULFAMETHOXAZOLE-TRIMETHOPRIM 65 52 65 91
GLIPIZIDE XL 65 51 65 95
RISPERIDONE 64 62 68 72
ACTOS 63 37 69 86
DILTIAZEM 24HR ER 61 45 70 143
LANTUS 59 56 71 66
RESTASIS 56 56 72 291
CARBIDOPA-LEVODOPA 54 32 73 142
ESTRADIOL 53 26 R 74 126
DOXAZOSIN MESYLATE 52 32 75 84
METOLAZONE 51 38 76 209
DIVALPROEX SODIUM 51 44 76 96
JANUVIA 51 41 76 68
ROPINIROLE HCL 51 29 76 108
BENICAR 50 50 80 187
PROMETHAZINE HCL 50 41 R 80 76
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 4, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.